Company: FEAV
Filing Date: 2025-03-04
Form Type: 8-K
Source: 0000950170-25-032427
Chunk: 0

Company: 5E Advanced Materials, Inc.
Filing Date: 2025-03-04
Form: 8-K
Item: Item 5.02
Chunk 0
---
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

As reported below under Item 5.07 of this Current Report on Form 8-K, on March 4, 2025, 5E Advanced Materials, Inc., a Delaware corporation (the “ Company”) held a Special Meeting of Stockholders (the “ Special Meeting”). At the Special Meeting, the Company’s stockholders approved an Amended and Restated 5E Advanced Materials, Inc. 2022 Equity Compensation Plan (the “ Plan” and as amended and restated, the “ Amended and Restated Plan”) to (i) increase the aggregate number of shares of common stock, par value $0.01 (“ Common Stock”) reserved for issuance under the Plan by 608,695 shares (reflecting proportional adjustments for the Company’s 1-for-23 reverse stock split effected on February 14, 2025 (the “ Reverse Stock Split”)), (ii) to allow the Company to grant incentive stock options (“ ISOs”) to eligible participants in an amount not to exceed 934,782 shares (reflecting proportional adjustments for the Reverse Stock Split), and provided that the Company may only grant ISOs through January 24, 2035, (iii) remove the Company’s ability to grant director restricted share units, and (iv) to increase the number of shares that may be issued to any individual (when combined with all of our other securities-based arrangements, as applicable) to 3% (increased from 2%) of the Company’s outstanding number of issued shares from time to time. The Amended and Restated Plan was adopted by the Company’s Board of Directors on January 24, 2025 and became effective on such date.

The terms and conditions of the Amended and Restated Plan are described in the section entitled “ Proposal Two - To approve the Amended and Restated 5E Advanced Materials, Inc. 2022 Equity Compensation Plan” in the Company’s Definitive Proxy Statement on Schedule 14A filed with the Securities and Exchange Commission on February 3, 2025 (the “ Special Meeting Proxy Statement”). The foregoing description of the Amended and Restated Plan does not purport to be complete and is qualified in its entirety by reference to the complete text of the Amended and Restated Plan, a copy of which is filed as Exhibit 10.1 hereto and is incorporated